Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Jul 31, 2014 06:06 PM ET

 Add to portfolio

$71.34 USD

-2.07 (-2.82%)

Zacks MF Rank : 5 - Strong Sell [?]         5

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jun 30, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jun 30, 2014) 13.44
Objective* Health Care - Equity
Peer* HL MG

*Key

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Sell 5
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 42.30
Net Assets (Mil $) 6/30/2014 313.32
%Turnover 6/30/2014 119.00

Allocation

% of Portfolio
Large Growth 29.58
Large Value 0.00
Small Growth 8.09
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 25.07
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 6/30/2014 % of Portfolio
Health 56.36
Services 22.82
Other 8.07
Technology 6.99
Industrial Cyclical 5.76

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.31 31.43
AMGEN INC 6.79 29.19
BIOGEN IDEC INC 5.76 24.75
CELGENE CORP 5.27 22.64
REGENERON PHARMACEUTICALS 3.77 16.22
ALEXION PHARMACEUTICALS I 3.74 16.09
ILLUMINA INC 3.02 12.97
VERTEX PHARMACEUTICALS IN 2.82 12.10
BIOMARIN PHARMACEUTICAL 2.12 9.11

Stock Holding % of Net Assets

As Of 3/31/2014
Total Issues 67
Avg. P/E 40.78
Avg. P/Book 5.76
Avg. EPS Growth 16.04
Avg. Market Value (Mil $) 27,811

Risk

3 Year 5 Year 10 Year
Beta 0.95 1.01 0.87
Alpha 15.57 8.28 7.36
R Squared 0.30 0.40 0.39
Std. Dev. 21.33 21.35 20.72
Sharpe 1.61 1.39 2.00